Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma

The clinical efficacy of immune checkpoint blockade has been recently demonstrated in a variety of cancer types. The aim of the present study was to characterize the expression profile of tumor-infiltrating lymphocytes (TILs) and programmed death-ligand 1 (PD-L1) in head and neck squamous carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Ze-Ming, Zhang, De-Jun, Guo, Ying-Yuan, Han, Shuang, Guo, Fang, Bai, Jie, Wan, Yi-Ning, Guan, Guo-Fang, Sun, Ke-Wei, Yang, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771311/
https://www.ncbi.nlm.nih.gov/pubmed/35111324
http://dx.doi.org/10.3892/mco.2022.2492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771311/
https://www.ncbi.nlm.nih.gov/pubmed/35111324
http://dx.doi.org/10.3892/mco.2022.2492

Ejemplares similares